Previous close | 4.0000 |
Open | N/A |
Bid | 3.8000 |
Ask | 4.2000 |
Strike | 5.00 |
Expiry date | 2024-06-21 |
Day's range | 4.0000 - 4.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11577 EPS, expectations were $-0.09. OPKO Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and […]
Q1 2024 OPKO Health Inc Earnings Call